OpenVSafe by OpenVAERS
Search V-safe

229-25253-69653

4 vaccinations 11 coded responses 36 check-ins 11 free-text entries 1 call case
Sex
Female
Age at first dose
61-65
ZIP prefix
722 / AR
Registered
2021-03-08
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-03-08
    Registered in v-safe
  2. 2021-03-08
    Dose 1 — Pfizer-BioNTech
  3. 2021-03-08
    Survey response — day 0, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  4. 2021-03-09
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  5. 2021-03-10
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-11
    Survey response — days 1–6 daily, dose 1
    MedDRA: Lymphadenopathy, SARS-CoV-2 test — Feeling: Good · Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Systemic reaction (other): Mammography performed today which is three days post-COVID-19. Doctor concerned about swollen lymph nodes in right breast. He feels lymph node swelling is related to COVID-19 vaccine which was taken in right arm. Ultrasound performed today, too. Follow up in three months is the plan. · Healthcare visit (other): Scheduled mammogram with an additional ultrasound secondary to swollen lymph nodes in right breast which doctor feels is related to COVID-19 vaccine in right arm 3 days ago.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-03-11
    Report sent to call center — days 1–6 daily, dose 1
    Get care from a doctor or other healthcare professional
    1 call case(s)
  8. 2021-03-13
    Survey response — days 1–6 daily, dose 1
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-03-14
    Health check-in — days 1–6 daily, dose 1
    Feeling: Good · None
    Adult check-in
  10. 2021-03-15
    Health check-in — day 7, dose 1
    Feeling: Fair · Fever · Chills, Headache · Be unable to work
    Adult check-in
  11. 2021-03-22
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  12. 2021-03-29
    Dose 2 — Pfizer-BioNTech
  13. 2021-03-29
    Survey response — day 0, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  14. 2021-03-30
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  15. 2021-03-31
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  16. 2021-04-01
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None.
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  17. 2021-04-02
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  18. 2021-04-03
    Survey response — days 1–6 daily, dose 2
    MedDRA: No adverse event — Feeling: Good
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  19. 2021-04-04
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Chills
    Adult check-in
  20. 2021-04-06
    Survey response — day 7, dose 2
    MedDRA: No adverse event — Feeling: Good · Chills
    Free text: None
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  21. 2021-04-12
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  22. 2021-04-20
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  23. 2021-04-26
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  24. 2021-05-03
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  25. 2021-05-11
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  26. 2021-06-28
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  27. 2021-09-27
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  28. 2021-10-28
    Dose 3 — Pfizer-BioNTech
  29. 2021-12-03
  30. 2022-03-31
    Health check-in — 12 months, dose 2
    Feeling: Good
    Adult check-in
  31. 2022-04-21
    Dose 4 — Pfizer-BioNTech
  32. 2022-04-23
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  33. 2022-04-24
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  34. 2022-04-25
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  35. 2022-04-27
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · None
    Adult check-in
  36. 2022-04-28
    Health check-in — day 7, dose 4
    Feeling: Good · None
    Adult check-in
  37. 2022-05-05
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  38. 2022-05-12
    Health check-in — day 21, dose 4
    Feeling: Good
    Adult check-in
  39. 2022-05-19
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  40. 2022-05-28
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  41. 2022-06-03
    Health check-in — day 42, dose 4
    Feeling: Good
    Adult check-in
  42. 2022-07-21
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  43. 2023-04-23
    Health check-in — 12 months, dose 4
    Feeling: Good
    Adult check-in

Vaccinations

DoseDateManufacturerCo-administered
12021-03-08Pfizer-BioNTech
22021-03-29Pfizer-BioNTech
32021-10-28Pfizer-BioNTech No
42022-04-21Pfizer-BioNTech No

Call center

1 call center case

1 unsuccessful

1 wait over 3 months for a first call

See the call center timeline

Free text

Release 5 — day 0, dose 1

2021-03-08

Systemic reaction (other): None

Release 5 — days 1–6 daily, dose 1

2021-03-10

Systemic reaction (other): None

2021-03-11

Systemic reaction (other): Mammography performed today which is three days post-COVID-19. Doctor concerned about swollen lymph nodes in right breast. He feels lymph node swelling is related to COVID-19 vaccine which was taken in right arm. Ultrasound performed today, too. Follow up in three months is the plan.
Healthcare visit (other): Scheduled mammogram with an additional ultrasound secondary to swollen lymph nodes in right breast which doctor feels is related to COVID-19 vaccine in right arm 3 days ago.

2021-03-13

Systemic reaction (other): None

Release 6 — day 0, dose 2

2021-03-29

Systemic reaction (other): None

Release 6 — days 1–6 daily, dose 2

2021-03-30

Systemic reaction (other): None.

2021-03-31

Systemic reaction (other): None

2021-04-01

Systemic reaction (other): None.

2021-04-02

Systemic reaction (other): None

2021-04-03

Systemic reaction (other): None

Release 7 — day 7, dose 2

2021-04-06

Systemic reaction (other): None

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOLymphadenopathy ✓ ✓ ✓
SROLymphadenopathy ✓ ✓ ✓
SRONo adverse event ✓ ✓ ✓
SROSARS-CoV-2 test ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…